Literature DB >> 24145188

Direct lineage reprogramming of mouse fibroblasts to functional midbrain dopaminergic neuronal progenitors.

Han-Seop Kim1, Janghwan Kim2, Yeonju Jo1, Daejong Jeon3, Yee Sook Cho4.   

Abstract

The direct lineage reprogramming of somatic cells to other lineages by defined factors has led to innovative cell-fate-change approaches for providing patient-specific cells. Recent reports have demonstrated that four pluripotency factors (Oct4, Sox2, Klf4, and c-Myc) are sufficient to directly reprogram fibroblasts to other specific cells, including induced neural stem cells (iNSCs). Here, we show that mouse fibroblasts can be directly reprogrammed into midbrain dopaminergic neuronal progenitors (DPs) by temporal expression of the pluripotency factors and environment containing sonic hedgehog and fibroblast growth factor 8. Within thirteen days, self-renewing and functional induced DPs (iDPs) were generated. Interestingly, the inhibition of both Jak and Gsk3β notably enhanced the iDP reprogramming efficiency. We confirmed the functionality of the iDPs by showing that the dopaminergic neurons generated from iDPs express midbrain markers, release dopamine, and show typical electrophysiological profiles. Our results demonstrate that the pluripotency factors-mediated direct reprogramming is an invaluable strategy for supplying functional and proliferating iDPs and may be useful for other neural progenitors required for disease modeling and cell therapies for neurodegenerative disorders.
© 2013.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24145188     DOI: 10.1016/j.scr.2013.09.007

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  16 in total

Review 1.  Understanding Parkinson's Disease through the Use of Cell Reprogramming.

Authors:  Rebecca Playne; Bronwen Connor
Journal:  Stem Cell Rev Rep       Date:  2017-04       Impact factor: 5.739

Review 2.  Generation of diverse neural cell types through direct conversion.

Authors:  Gayle F Petersen; Padraig M Strappe
Journal:  World J Stem Cells       Date:  2016-02-26       Impact factor: 5.326

Review 3.  Induced neural stem/precursor cells for fundamental studies and potential application in neurodegenerative diseases.

Authors:  Ting Shen; Jiali Pu; Tingting Zheng; Baorong Zhang
Journal:  Neurosci Bull       Date:  2015-06-15       Impact factor: 5.203

4.  Regenerative Medicine for the Aging Brain.

Authors:  Micaela Lopez-Leon; Paula C Reggiani; Claudia B Herenu; Rodolfo G Goya
Journal:  Enliven J Stem Cell Res Regen Med       Date:  2014

Review 5.  Biomaterials for recruiting and activating endogenous stem cells in situ tissue regeneration.

Authors:  Ingrid Safina; Mildred C Embree
Journal:  Acta Biomater       Date:  2022-03-12       Impact factor: 10.633

Review 6.  The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders.

Authors:  Derek K Smith; Miao He; Chun-Li Zhang; Jialin C Zheng
Journal:  Prog Neurobiol       Date:  2016-02-01       Impact factor: 11.685

7.  Direct and selective lineage conversion of human fibroblasts to dopaminergic precursors.

Authors:  Miao He; Hainan Zhang; Yuju Li; Changhai Tian; Beisha Tang; Yunlong Huang; Jialin Zheng
Journal:  Neurosci Lett       Date:  2019-01-18       Impact factor: 3.046

8.  Botanical Drug Puerarin Attenuates 6-Hydroxydopamine (6-OHDA)-Induced Neurotoxicity via Upregulating Mitochondrial Enzyme Arginase-2.

Authors:  Jia Zhao; Yuanyuan Cheng; Chuanbin Yang; Sam Lau; Lixing Lao; Bo Shuai; Jing Cai; Jianhui Rong
Journal:  Mol Neurobiol       Date:  2015-05-08       Impact factor: 5.590

Review 9.  Advances in Stem Cell Research- A Ray of Hope in Better Diagnosis and Prognosis in Neurodegenerative Diseases.

Authors:  Shripriya Singh; Akriti Srivastava; Pranay Srivastava; Yogesh K Dhuriya; Ankita Pandey; Dipak Kumar; Chetan S Rajpurohit
Journal:  Front Mol Biosci       Date:  2016-11-08

10.  Development of stem cell-based therapy for Parkinson's disease.

Authors:  Fabin Han; Deborah Baremberg; Junyu Gao; Jing Duan; Xianjie Lu; Nan Zhang; Qingfa Chen
Journal:  Transl Neurodegener       Date:  2015-09-03       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.